IGF2BP2 and leukemia: It has been shown that the m6A-binding protein IGF2BP2 promotes AML development and leukemia stem cell (LSC) self-renewal in an m6A-dependent manner by regulating key targets in the glutamine metabolism pathway (such as MYC, GPT2, and SLC1A5).